Neuroimaging studies over the last few years have demonstrated that exposure to maternal depression can lead to changes in the architecture of the child’s brain, changes which may persist into adulthood and are associated with [...]
Over the last decade, public awareness of the mental health challenges women face has grown tremendously, and we can say with certainty that we have succeeded in putting this important topic firmly on the medical [...]
Since the the Food and Drug Administration (FDA) approved brexanolone as an intravenous infusion for the treatment of postpartum depression last week, we have been deluged with questions from patents, providers and the media regarding [...]
In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of postpartum depression (PPD). Â SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors. Â Since that time, Sage Therapeutics [...]
Postpartum depression (PPD) is a common and complicated illness, affecting about 15% of women in the perinatal period. Recent research from the PACT consortium (Postpartum Depression: Action Toward Causes and Treatment) has sought to classify [...]
Women with postpartum depression often complain of social isolation, and multiple studies have documented that having inadequate social supports is a risk factor for postpartum depression.  A recent study suggests that increasing a mother’s social [...]
In 2016, the US Preventive Services Task Force (USPSTF) recommended that all adults, including pregnant and postpartum women, should be screened for depression; the task force has extended those recommendations by stating that all pregnant [...]
January 30, 2019 from ObGynNews  The last decade has brought appropriate attention to the high prevalence of postpartum mood and anxiety disorders, with postpartum depression (PPD) constituting the most common complication in modern obstetrics. [...]
While there is some data to indicate that exercise may improve well-being and diminish symptoms of depression and anxiety, the results have been mixed. Â A recent randomized controlled trial has explored the efficacy of [...]
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on preventing postpartum depression with Ob.Gyn News on January 30, 2019 The last decade [...]
